Toronto-based global medical cannabis producer Tilray Canada Ltd. announced January 19 that it agreed to supply medical cannabis to Shoppers Drug Mart, one of Canada’s leading drug retailers with over 1,200 locations. Shopper’s also licenses and/or owns 49 medical clinic pharmacies.
Tilray’s branded cannabis products will likely be sold online, as Canadian regulations currently restrict medical cannabis in retail pharmacies.
“Tilray’s products are currently sold in pharmacies in 7 countries around the world. …we aim to build the world’s leading medical cannabis brand by increasing availability of …pharmaceutical-grade cannabis products…,” said Brendan Kennedy, Tilray CEO.
Tilray is a global leader in research, production and distribution of medical cannabis and cannabinoids. It was the first licensed producer in North America to be EU GMP-certified to produce medical cannabis. The company currently serves tens of thousands of patients, physicians, pharmacies, governments, hospitals, and researchers on four continents through its affiliates in Australia, New Zealand, Canada, Germany, and Portugal.